insights_auto
Why is GOVX down 2.58%?
Dive Deeperchevron_right
GOVX:NASDAQ
Geovax Labs Inc
$0.35
arrow_downward
-2.58%(-0.0093) 1D
$0.33
arrow_downward
-4.87% (-0.017)todayPre-market
Closed: Sep 25, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$0.37
High
$0.38
Low
$0.35
Mkt. cap
3.19M
Avg. vol.
959.57K
Volume
4.25K
52-wk high
$16.50
52-wk low
$0.35
EPS
-$13.92
Beta
3.66
Shares outstanding
10.10M
No. of employees
19
Open
$0.37
High
$0.38
Low
$0.35
Mkt. cap
3.19M
Avg. vol.
959.57K
Volume
4.25K
52-wk high
$16.50
52-wk low
$0.35
EPS
-$13.92
Beta
3.66
Shares outstanding
10.10M
No. of employees
19
News stories
From web sources and news partners
https://www.dars.gov.et/
·
2 months ago
GeoVax Labs (GOVX) Tumbles 13% as Biotech Stock Tests Key Support at $0.69 - Bollinger Expansion
https://www.dars.gov.et/
·
2 months ago
GOVX Q1 2026 Earnings: Narrower Loss Beats Estimates as GeoVax Advances Vaccine Pipeline - Revenue Growth Report
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitegeovax.com